Latent tuberculosis in a newborn: diagnostic challenges.
In countries where the incidence of tuberculosis is low, perinatal tuberculosis is seldom diagnosed. With increasing numbers of human immunodeficiency virus-infected people and increasing immigrant population from high tuberculosis incidence countries, one might expect perinatal tuberculosis to become more frequent. Early recognition of newborns at risk for perinatal tuberculosis infection is of utmost importance to prevent disease by chemoprophylaxis. We describe a case of latent perinatal tuberculosis infection in a newborn infected from a mother with extrapulmonary primary tuberculosis. Tuberculin skin test was negative, and latent tuberculosis infection was eventually diagnosed by specific immunological tests. We discuss the difficulties in diagnosis of recent tuberculosis infection in neonates and infants, and the risk factors for vertical transmission of tuberculosis, which need to be taken into account in considering the need for chemoprophylaxis in the newborn. Although perinatal TB infection is a rare condition and diagnosis is difficult due to poor diagnostic testing in pregnancy and newborns, a high index of suspicion is needed to limit the diagnostic delay and to avoid progression to perinatal TB disease.
De Schutter
Iris
I
Department of Pediatrics, Pediatric Pulmonology, Cystic Fibrosis Clinic and Pediatric Infectious Diseases, Universitair Ziekenhuis Brussel UZ Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium. iris.deschutter@uzbrussel.be
Schepers
Kinda
K
Singh
Mahavir
M
Mascart
Françoise
F
Malfroot
Anne
A
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D007159:Immunologic Tests; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical; D055985:Latent Tuberculosis / Q000175:diagnosis* / Q000517:prevention & control / Q000635:transmission*; D011247:Pregnancy; D014374:Tuberculin Test; D014396:Tuberculosis, Pleural / Q000175:diagnosis / Q000188:drug therapy / Q000635:transmission*
D000995:Antitubercular Agents
Am J Respir Crit Care Med. 2004 Aug 1;170(3):288-95
15130907
Lancet Infect Dis. 2003 Oct;3(10):624-32
14522261
Early Hum Dev. 2008 Dec;84(12):795-9
18823726
Lancet Infect Dis. 2004 Mar;4(3):155-65
14998501
MMWR Recomm Rep. 2003 Jun 20;52(RR-11):1-77
12836625
Clin Infect Dis. 2006 Jun 1;42(11):e82-5
16652300
PLoS One. 2009;4(1):e4130
19125189
Eur J Immunol. 2001 May;31(5):1531-5
11465110
Int J Tuberc Lung Dis. 2004 May;8(5):658-74
15137550
Cell Immunol. 1980 Sep 15;55(1):191-200
6159105
Curr Opin Pediatr. 2010 Feb;22(1):71-6
19952926
Int J Tuberc Lung Dis. 2004 Jan;8(1):59-69
14974747
Pediatrics. 2007 Jan;119(1):e1-5
17200234
J Immunol. 2003 Feb 1;170(3):1504-9
12538714